We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+1.59%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$113M
AUM Growth
+$9.44M
Cap. Flow
+$7.87M
Cap. Flow %
6.95%
Top 10 Hldgs %
84.01%
Holding
47
New
4
Increased
28
Reduced
11
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 3.94%
2 Technology 2.3%
3 Financials 0.95%
4 Industrials 0.47%
5 Consumer Staples 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
26
Medtronic
MDT
$106B
$411K 0.36%
4,280
+135
+3% +$13.1K
UWM icon
27
ProShares Ultra Russell2000
UWM
$277M
$375K 0.33%
7,977
+32
+0.4% +$1.51K
TMO icon
28
Thermo Fisher Scientific
TMO
$198B
$339K 0.3%
+586
New +$331K
REGN icon
29
Regeneron Pharmaceuticals
REGN
$70.9B
$329K 0.29%
427
+15
+4% +$10.2K
HYG icon
30
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$265K 0.23%
3,290
+61
+2% +$4.92K
TIP icon
31
iShares TIPS Bond ETF
TIP
$14.5B
$245K 0.22%
2,228
+17
+0.8% +$1.89K
IGF icon
32
iShares Global Infrastructure ETF
IGF
$10.9B
$244K 0.22%
3,968
+63
+2% +$3.89K
PM icon
33
Philip Morris
PM
$301B
$230K 0.2%
1,437
+13
+0.9% +$2.01K
LQD icon
34
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$223K 0.2%
2,021
+30
+2% +$3.33K
MIRM icon
35
Mirum Pharmaceuticals
MIRM
$7.25B
$210K 0.19%
+2,663
New +$191K
DHR icon
36
Danaher
DHR
$144B
$209K 0.18%
915
-398
-30% -$87.5K
ZURA icon
37
Zura Bio
ZURA
$518M
$103K 0.09%
19,577
-1,941
-9% -$7.67K
BCYC
38
Bicycle Therapeutics
BCYC
$294M
$94.7K 0.08%
+13,371
New +$98.6K
CTMX icon
39
CytomX Therapeutics
CTMX
$788M
$79.7K 0.07%
18,699
+590
+3% +$2.24K
NKTX icon
40
Nkarta
NKTX
$186M
$75.3K 0.07%
40,702
+1,250
+3% +$2.5K
GERN icon
41
Geron
GERN
$924M
$67.7K 0.06%
51,320
-938
-2% -$1.18K
ANNX icon
42
Annexon
ANNX
$950M
$66.4K 0.06%
13,226
-13,801
-51% -$52.8K
MREO
43
Mereo BioPharma
MREO
$49.5M
$13.2K 0.01%
31,768
-1,412
-4% -$2.69K
EDV icon
44
Vanguard World Funds Extended Duration ETF
EDV
$3.37B
-9,504
Closed -$651K
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$774B
-2,752
Closed -$1.83M
USMV icon
46
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
-45,153
Closed -$4.3M
VB icon
47
Vanguard Small-Cap ETF
VB
$79.7B
-9,534
Closed -$2.42M

Similar funds

Forefront Analytics's Q4 2025 Portfolio in Review

As of Q4 2025, Forefront Analytics held 47 positions worth $113M, up 9.1% from $104M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Forefront Analytics deployed $7.87M of net new capital in Q4 2025, opening 4 new positions and adding to 28 existing holdings. Its largest new stake was iShares Core Conservative Allocation ETF: 58,682 shares worth $2.35M.

By sector, the portfolio is most concentrated in Healthcare at 3.9% of assets, up from 3% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Nuveen ESG Large-Cap Value ETF, an estimated $4.76M trimmed.

  • Forefront Analytics's largest Q4 2025 buy was iShares Core Conservative Allocation ETF: 58,682 shares worth $2.35M.
  • Forefront Analytics added most to iShares ESG Aware MSCI EM ETF in Q4 2025, an estimated $7.31M increase.
  • Forefront Analytics's biggest Q4 2025 reduction was Nuveen ESG Large-Cap Value ETF, cutting an estimated $4.76M.
  • Forefront Analytics fully exited iShares MSCI USA Min Vol Factor ETF in Q4 2025, selling an estimated $4.3M.
  • Forefront Analytics's ten largest holdings make up 84% of its $113M portfolio in Q4 2025.
  • Forefront Analytics opened 4 new positions and closed 4 in Q4 2025.
  • Forefront Analytics's portfolio value rose 9.1% quarter-over-quarter to $113M.

Based on Forefront Analytics's 13F filing for Q4 2025, filed 17 Feb 2026.